Pilot Requests

Pilot programs provide controlled validation of managed GLP-1 tapering protocols within specific employer cohorts before broader deployment.

Pilot objectives

Pilots validate cost reduction projections, test protocol adherence, measure clinical safety outcomes, and establish operational workflows. Pilots are designed to produce decision-ready data for full program authorization.

Minimum cohort requirements

Pilots require minimum cohort sizes to produce statistically meaningful outcomes. Typical minimum is 50-100 members on GLP-1 medications with sufficient metabolic stability data. Smaller cohorts may be considered for specialized populations.

Pilot duration

Pilot programs typically run 6-12 months to capture sufficient outcome data for validation. Duration depends on tapering protocol velocity and measurement requirements.

What is included

Pilot programs include initial exposure analysis, cohort segmentation, protocol execution, member communication, prescriber coordination, ongoing monitoring, and outcome reporting. Pilots operate with the same clinical rigor as full-scale programs.

Pilot pricing

Pilot pricing is structured as a fixed engagement fee plus per-member-per-month costs for active tapering participants. Pricing is provided during pilot scoping discussions.

How to request a pilot

To request a pilot, provide employer population size, current GLP-1 spend (if known), and organizational decision-making structure. We will respond with preliminary qualification assessment and next steps.